TrialBMC cancer2021

Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials.

Senri Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.